Sensex ends over 100 pts lower, Nifty below 10,400; RIL, Infy down 1% each
All that happened in the market today
 ".")
Investor confidence in China has been dented by rising bond yields as Beijing steps up its crackdown on shadow banking and other risky forms of financing. Higher borrowing costs threaten to squeeze corporate profits.
Back home, November expiry has been a mixed affair so far. Market-wide rollovers on the D-3 came in at 27% which is on the higher side compared to the average rollovers of 21% of the last three series. Nifty futures rollovers, meanwhile, stood at 32% which is also high compared to the average rollovers of 18% of the last three series.
3:45 PM
Market rundown by Anand James, Chief Market Strategist, Geojit Financial Services
"Stocks gave away the early gains as the investors became cautious ahead of the September quarter GDP data release scheduled on Thursday. Decent rollover numbers may be suggestive of the short term positivity in the market, with sectoral continuing to continuing to roll in, this time along home finance companies which rose after government’s proposal to tax unsold realty inventory stoked expectations of more activity in the housing sector. Global cues remain muted for now, setting the stage for OPEC's meeting on Thursday and voting on US Tax reform bill."
3:40 PM
Top Sectoral loser: Nifty PSU Bank index
Source: NSE
3:39 PM
Sectoral Trend
Source: NSE
3:36 PM
Top Sensex gainers and losers
Source: BSE
3:34 PM
Broader Markets
The broader markets were outperforming the benchmark indices with BSE Midcap and BSE Smallcap indices up 0.1% and 0.3% respectively
The broader markets were outperforming the benchmark indices with BSE Midcap and BSE Smallcap indices up 0.1% and 0.3% respectively
3:34 PM
Markets at close
Benchmark indices ended lower on Tuesday, weighed down by market heavyweights such as Reliance Industries and Infosys, with investors now focussed on September-quarter GDP data, due on Thursday
The S&P BSE SEnsex ended at 33,618, sown 105 points while the broader Nifty50 index settled the day at 10,370, down 29 points
Benchmark indices ended lower on Tuesday, weighed down by market heavyweights such as Reliance Industries and Infosys, with investors now focussed on September-quarter GDP data, due on Thursday
The S&P BSE SEnsex ended at 33,618, sown 105 points while the broader Nifty50 index settled the day at 10,370, down 29 points
3:21 PM
Order Win
State-owned power equipment maker BHEL has bagged an order worth Rs 64 crore for setting up six decentralised sewage treatment plants in Raipur, Chhattisgarh.
"Valued at over Rs 64 crore, the order for sewage treatment plants with a cumulative capacity of 25.4 million litres per day, has been placed on BHEL by Raipur Development Authority," the company said in its filing.
3:10 PM
Eris Life extends rally post acquisition of Strides' India branded business
Eris Lifesciences moved higher by 11% to Rs 721, extending its 11% gain of the last six trading sessions after the company acquired the domestic formulations business of Strides Shasun in an Rs 500-crore deal, marking its foray into the fast-growing central nervous system (CNS) segment.
According to media report, Credit Suisse initiated coverage of Eris Lifesciences with a recommendation of outperform with price target of Rs 770 per share within a year.
Eris Lifesciences and Strides Shasun signed an agreement on Saturday, November 18, in which Eris Lifesciences will acquire 130 Strides Shasun brands in the neurology, nutraceuticals and gastrointestinal segments, along with employees who form part of the business. READ MORE
3:00 PM
Market Check
| Index | Current | Pt. Change | % Change |
| S&P BSE SENSEX | 33,600.65 | -123.79 | -0.37 |
| S&P BSE SENSEX 50 | 10,807.86 | -33.17 | -0.31 |
| S&P BSE SENSEX Next 50 | 35,870.11 | -6.39 | -0.02 |
| S&P BSE 100 | 10,837.01 | -28.07 | -0.26 |
| S&P BSE Bharat 22 Index | 3,741.97 | -22.70 | -0.60 |
2:48 PM
Nifty PSU Bank index down over 1%
Source: NSE
2:34 PM
Glenmark Pharma falls 3% as Baddi unit gets 7 observations from USFDA
Glenmark Pharmaceuticals dipped 3% to Rs 574 on the BSE in intra-day trade after the company said its Baddi unit gets seven observations from US health regulator.
“The US Food and Drug Administration (USFDA) issued seven observations through the form 483,” Glenmark Pharmaceuticals said in a regulatory filing.
The Baddi unit of Glenmark Pharmaceuticals underwent an US FDA audit from November 6, 2017 to November 11, 2017. The Baddi unit contributes approximately 10% of the revenue of US sales. READ MORE
2:17 PM
Buzzing in trade
Eris Lifesciences surged 5.13% to Rs 683.60 on BSE on reports a global brokerage house has initiated coverage with outperform call on the stock.
2:02 PM
Trai issues recos on net neutrality
Telecom regulator, TRAI, has issued recommendations on net neutrality. The two major recommendations are: 1) Internet service providers must not engage in discriminatory treatment of content, and 2) Licensee can't enter into an agreement that has any discriminatory content effect.
Telecom regulator, TRAI, has issued recommendations on net neutrality. The two major recommendations are: 1) Internet service providers must not engage in discriminatory treatment of content, and 2) Licensee can't enter into an agreement that has any discriminatory content effect.
The Telecom Regulatory Authority of India (TRAI) on Tuesday also recommended an amendment to licence agreement with regard to internet services providers (ISPs), among other recommendations for the much-awaited net neutrality debate.
1:48 PM
Top Sensex gainers and losers
Source: BSE
1:35 PM
Broader Markets
The broader markets continued to outperform equity benchmarks in afternoon, with the Nifty Midcap index trading near its record high level.
The broader markets continued to outperform equity benchmarks in afternoon, with the Nifty Midcap index trading near its record high level.
Topics :
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 28 2017 | 3:30 PM IST
